RE:Just crazy. Probably there is a reason why Aristotle has no traction in the general market. There exists already tests that measure the number of cancer cells in the blood for many years now except that it doesn't identify what type like Aristotle. Therefore, it could detect cancer cells that hasn't necessarily multiplied to affect the health of a person. Furthermore, is it necessary to start a cancer treatment not knowing if it will develop or not? Every person from the day we are born to the day we die produce cancer cells that our body usually eliminates them unless our body has a medical condition or environmental condition cause a full blown cancer.
Here is an interesting link:
https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/cancer-diagnosis/art-20046459 VerifiedUser123 wrote: We've launched Aristotle and we're at 6 pennies. Why do we even have a CEO. He's clearly not doing his job